These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1873218)

  • 1. The anti-mitozantrone monoclonal antibody NO-1, protects acute leukaemia cell lines from the cytotoxic effects of mitozantrone.
    Flavell SU; Flavell DJ
    Br J Haematol; 1991 Jul; 78(3):330-3. PubMed ID: 1873218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a sensitive monoclonal antibody-based enzyme-linked immunosorbent assay (ELISA) for mitozantrone.
    Flavell SU; Flavell DJ
    J Immunol Methods; 1988 Dec; 115(2):179-85. PubMed ID: 3198922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitozantrone-induced onycholysis. A series of five cases.
    Creamer JD; Mortimer PS; Powles TJ
    Clin Exp Dermatol; 1995 Nov; 20(6):459-61. PubMed ID: 8857336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitozantrone-induced toxicity and DNA strand breaks in leukaemic cells.
    Ho AD; Seither E; Ma DD; Prentice HG
    Br J Haematol; 1987 Jan; 65(1):51-5. PubMed ID: 3468998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation.
    Zola H; Potter A; Neoh SH; Juttner CA; Haylock DN; Rice AM; Favaloro EJ; Kabral A; Bradstock KF
    Bone Marrow Transplant; 1987 Feb; 1(3):297-301. PubMed ID: 3332140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibody.
    Csóka M; Strauss G; Debatin KM; Moldenhauer G
    Leukemia; 1996 Nov; 10(11):1765-72. PubMed ID: 8892680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox cycling in MCF-7 human breast cancer cells by antitumor agents based on mitozantrone.
    Fisher GR; Brown JR; Patterson LH
    Free Radic Res Commun; 1989; 7(3-6):221-6. PubMed ID: 2555276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody specific for human T acute lymphoblastic leukaemia.
    Deng C; Terasaki P; Chia J; Billing R
    Lancet; 1982 Jan; 1(8262):10-1. PubMed ID: 6119411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia.
    Hoelzer D
    Curr Opin Oncol; 2013 Nov; 25(6):701-6. PubMed ID: 24097105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
    Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.
    Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S
    Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo.
    French RR; Courtenay AE; Ingamells S; Stevenson GT; Glennie MJ
    Cancer Res; 1991 May; 51(9):2353-61. PubMed ID: 2015599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies and complement purged autograft in Burkitt lymphoma and lymphoblastic leukemia.
    Favrot M; Philip I; Combaret V; Pavone E; Bouffet E; Biron P; Philip T
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():202-4. PubMed ID: 2713555
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
    Raso V; Ritz J; Basala M; Schlossman SF
    Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future role of monoclonal antibody therapy in childhood acute leukaemias.
    Barth M; Raetz E; Cairo MS
    Br J Haematol; 2012 Oct; 159(1):3-17. PubMed ID: 22881237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bispecific monoclonal antibody recognizing both hepatoma-specific membrane glycoprotein and anthracycline drugs on the metastatic growth of hepatoma AH66.
    Tsukada Y; Ohkawa K; Hibi N; Tsuzuki K; Oguma K; Satoh H
    Cancer Biochem Biophys; 1989 May; 10(3):247-56. PubMed ID: 2789098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancer.
    Joshua AM; Nordman I; Venkataswaran R; Clarke S; Stockler MR; Boyer MJ
    Intern Med J; 2005 Aug; 35(8):468-72. PubMed ID: 16176469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The toxicity of menadione and mitozantrone in human liver-derived Hep G2 hepatoma cells.
    Duthie SJ; Grant MH
    Biochem Pharmacol; 1989 Apr; 38(8):1247-55. PubMed ID: 2539822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
    Dillman RO; Johnson DE; Ogden J; Beidler D
    Mol Biother; 1989; 1(5):250-5. PubMed ID: 2515870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.